EML4 and non-small cell lung carcinoma: Kang eat al. described 11 NSCLC patients with huntingtin-interacting protein 1 (HIP1)-ALK rearrangements, among whom one patient with adenosquamous cell cancer harbored three fusions (EML4-ALK, HIP1-ALK, and ALK-PLEKHH20).